These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35822414)

  • 21. The Integral Role of the Electronic Health Record and Tracking Software in the Implementation of Lung Cancer Screening-A Call to Action to Developers: A White Paper From the National Lung Cancer Roundtable.
    Fathi JT; White CS; Greenberg GM; Mazzone PJ; Smith RA; Thomson CC
    Chest; 2020 Jun; 157(6):1674-1679. PubMed ID: 31877270
    [No Abstract]   [Full Text] [Related]  

  • 22. Analysis of Lung Cancer Screening by Race After USPSTF Expansion of Screening Eligibility in 2021.
    Shusted CS; Evans NR; Kane GC; Juon HS; Barta JA
    JAMA Netw Open; 2022 Jun; 5(6):e2217578. PubMed ID: 35704319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of Biomarker Testing for Lung Cancer Screening Eligibility.
    Larose TL; Meheus F; Brennan P; Johansson M; Robbins HA
    JAMA Netw Open; 2020 Mar; 3(3):e200409. PubMed ID: 32134462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Piloting electronic screening forms in primary care: findings from a mixed methods study to identify patients eligible for low dose CT lung cancer screening.
    O'Brien MA; Sullivan F; Carson A; Siddiqui R; Syed S; Paszat L
    BMC Fam Pract; 2017 Nov; 18(1):95. PubMed ID: 29179686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing Different Approaches to Leveraging Historical Smoking Exposure Data to Better Select Lung Cancer Screening Candidates: A Retrospective Validation Study.
    Kats DJ; Adie Y; Tlimat A; Greco PJ; Kaelber DC; Tarabichi Y
    Nicotine Tob Res; 2021 Aug; 23(8):1334-1340. PubMed ID: 32974635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk-based lung cancer screening eligibility criteria: towards implementation.
    Ten Haaf K
    Lancet Oncol; 2022 Jan; 23(1):13-14. PubMed ID: 34902333
    [No Abstract]   [Full Text] [Related]  

  • 27. Stratification and management of patients ineligible for lung cancer screening.
    Aggarwal R; Lam AC; Huang J; Hueniken K; Nguyen D; Khan K; Shaikh T; Shepherd FA; Tsao MS; Xu W; Kavanagh J; Liu G
    Respir Med; 2021 Nov; 188():106610. PubMed ID: 34592536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluating Eligibility of US Black Women Under USPSTF Lung Cancer Screening Guidelines.
    Potter AL; Yang CJ; Woolpert KM; Puttaraju T; Suzuki K; Palmer JR
    JAMA Oncol; 2022 Jan; 8(1):163-164. PubMed ID: 34817564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Broadened Eligibility for Lung Cancer Screening: Challenges and Uncertainty for Implementation and Equity.
    Henderson LM; Rivera MP; Basch E
    JAMA; 2021 Mar; 325(10):939-941. PubMed ID: 33687453
    [No Abstract]   [Full Text] [Related]  

  • 30. Estimating eligibility for lung cancer screening in an Australian cohort, including the effect of spirometry.
    Manners D; Hui J; Hunter M; James A; Knuiman MW; McWilliams A; Mulrennan S; Musk AW; Brims FJ
    Med J Aust; 2016 Jun; 204(11):406. PubMed ID: 27318396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Impact of Fluctuations in Pack-Year Smoking History in the Electronic Health Record on Lung Cancer Screening Practices.
    Tarabichi Y; Kats DJ; Kaelber DC; Thornton JD
    Chest; 2018 Feb; 153(2):575-578. PubMed ID: 29406227
    [No Abstract]   [Full Text] [Related]  

  • 32. Time to quit using quit time as a lung cancer screening eligibility criterion.
    Tammemägi MC
    Cancer; 2024 Jan; 130(2):182-185. PubMed ID: 37658650
    [No Abstract]   [Full Text] [Related]  

  • 33. Tobacco use and motivation to stop smoking among long-term smokers who are ineligible for lung cancer screening.
    Taghizadeh N; Taylor KL; MacEachern P; Koetzler R; Dickinson JA; Gillson A; Yang H; Tammemagi MC; Penz E; Pendharkar SR; Lam SC; Graham A; Culling J; Burrowes P; Bédard ELR; Tremblay A
    Lung Cancer; 2017 Sep; 111():101-107. PubMed ID: 28838378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Addressing Disparities in Lung Cancer Screening Eligibility and Healthcare Access. An Official American Thoracic Society Statement.
    Rivera MP; Katki HA; Tanner NT; Triplette M; Sakoda LC; Wiener RS; Cardarelli R; Carter-Harris L; Crothers K; Fathi JT; Ford ME; Smith R; Winn RA; Wisnivesky JP; Henderson LM; Aldrich MC
    Am J Respir Crit Care Med; 2020 Oct; 202(7):e95-e112. PubMed ID: 33000953
    [No Abstract]   [Full Text] [Related]  

  • 35. Selecting High-Risk Individuals for Lung Cancer Screening: A Prospective Evaluation of Existing Risk Models and Eligibility Criteria in the German EPIC Cohort.
    Li K; Hüsing A; Sookthai D; Bergmann M; Boeing H; Becker N; Kaaks R
    Cancer Prev Res (Phila); 2015 Sep; 8(9):777-85. PubMed ID: 26076698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A more effective approach to lung cancer screening?: Researchers have developed a new risk prediction model to help inform patients and their physicians whether they should undergo lung cancer screening and, if so, when.
    Printz C
    Cancer; 2020 Feb; 126(4):691-692. PubMed ID: 31995243
    [No Abstract]   [Full Text] [Related]  

  • 37. Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.
    Ten Haaf K; Jeon J; Tammemägi MC; Han SS; Kong CY; Plevritis SK; Feuer EJ; de Koning HJ; Steyerberg EW; Meza R
    PLoS Med; 2017 Apr; 14(4):e1002277. PubMed ID: 28376113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered?
    Pinsky PF; Berg CD
    J Med Screen; 2012 Sep; 19(3):154-6. PubMed ID: 23060474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Economic impact of using risk models for eligibility selection to the International lung screening Trial.
    Cressman S; Weber MF; Ngo PJ; Wade S; Behar Harpaz S; Caruana M; Tremblay A; Manser R; Stone E; Atkar-Khattra S; Karikios D; Ho C; Fernandes A; Yi Weng J; McWilliams A; Myers R; Mayo J; Yee J; Yuan R; Marshall HM; Fong KM; Lam S; Canfell K; Tammemägi MC
    Lung Cancer; 2023 Feb; 176():38-45. PubMed ID: 36592498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross sectional study to assess the accuracy of electronic health record data to identify patients in need of lung cancer screening.
    Cole AM; Pflugeisen B; Schwartz MR; Miller SC
    BMC Res Notes; 2018 Jan; 11(1):14. PubMed ID: 29321038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.